Skip to main content

Advertisement

Table 3 Availability of misoprostol prevention doses: % (95% CI)

From: Scaling up interventions: findings and lessons learned from an external evaluation of Niger’s National Initiative to reduce postpartum hemorrhage

  Phase 1 (n = 60) Phase 2 (n = 60) p-value
Received at least 1 procurement 96.5 (92.3, 98.5) 98.2 (96.3, 99.2) P = .23
Experienced stock out within the last 12 months 23.5 (10.0, 45.9) 28.7 (16.8, 44.5) p = .64
Stock out duration within last 12 months
 Never 76.5 (54.1, 90.0) 72.7 (56.4, 84.5) p = .68
 Less than 1 month 12.9 (4.6, 31.1) 19.8 (9.5, 36.7)
 1–3 months 9.2 (2.4, 29.1) 7.5 (3.1, 17.3)
 Over 3 months 1.4 (0.2, 10.2) 0
Expired stock at time of data collection 18 (7.3, 38.1) 20.4 (9.6, 38.4) P = .81